Journal Report

Journal of dermatological treatment (The)

Download PDF
Journal Information
Journal Title
Journal of dermatological treatment (The)
Publisher
ISSN
0954-6634
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Disease control of atopic dermatitis in people receiving dupilumab treatment: a plain language summary of the real-world study on Atopic Dermatitis Control Tool in the Gulf countries
Amani Alfalasi, Ahmed Ameen, Atlal Al Lafi et al.
2026-11-4 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2739741
Gastrointestinal safety signals of Janus kinase inhibitors: a real-world pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System
Esra Kiratli Nalbant, Banu Ismail Mendi
2026-11-4 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2757905
Treatment patterns and clinical burden in adults and children with plaque psoriasis: a real-world survey
Elizabeth (Lisa) Swanson, William Malatestinic, James Lucas et al.
2026-11-4 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2756788
Prescription coverage barriers persist for atopic dermatitis patients despite an expanding treatment landscape: findings from a 2025 national survey
Allison R. Loiselle, Jessica K. Johnson, Wendy Smith Begolka
2026-11-3 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2756043
Balancing safety and efficacy in photodynamic therapy for facial port-wine stains in children aged 2-7 years: a prospective controlled study of light-intensity optimization
Jiawen Qin, Xiaoxi Lin, Yue Han et al.
2026-10-23 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2734962
5-Aminolevulinic acid-based photodynamic therapy used as a long-term management approach for refractory lichen sclerosus
Yitao Qian, Wenjing Zha, Jie Shen et al.
2026-10-21 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2746298
Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis
Raj Chovatiya, Marjolein de Bruin-Weller, Andrew Alexis et al.
2026-10-19 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2713286
Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained response
Abdullah Demirbas, Esin Diremsizoglu
2026-10-18 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2748762
Surgical management of dissecting cellulitis of the scalp: a narrative review of techniques, patient selection, and integration with medical therapy
Junyou Zheng, Wenbo Bu, Xiaofang Li et al.
2026-10-16 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2748257
A cross-sectional analysis of topical steroid phobia and observable side effects in Thai psoriasis patients
Pimmada Piemmongkolchai, Chawengsak Khamkaen, Thanakorn Woramongkol et al.
2026-10-15 Vol. 37 Issue 1
DOI: 10.1080/09546634.2026.2748079
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 01:29